Psychological therapies for people with borderline personality disorder
Referencias
Additional references
Akiskal HS. Demystifying borderline personality: critique of the concept and unorthodox reflections on its natural kinship with the bipolar spectrum. Acta Psychiatrica Scandinavica 2004;110(6):401‐7. [DOI: 10.1111/j.1600‐0447.2004.00461.x; PUBMED: 15521823]
Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck‐Ytter Y, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. Journal of Clinical Epidemiology 2013;66(7):719–25. [DOI: 10.1016/j.jclinepi.2012.03.013; PUBMED: 23312392]
Andrews JC, Schünemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, et al. GRADE guidelines: 15. Going from evidence to recommendation ‐ determinants of a recommendation’s direction and strength. Journal of Clinical Epidemiology 2013;66(7):726–35. [DOI: 10.1016/j.jclinepi.2013.02.003; PUBMED: 23570745]
Ansell EB, Sanislow CA, McGlashan TH, Grilo CM. Psychosocial impairment and treatment utilization by patients with borderline personality disorder, other personality disorders, mood and anxiety disorders, and a healthy comparison group. Comprehensive Psychiatry 2007;48(4):329‐36. [DOI: 10.1016/j.comppsych.2007.02.001; PUBMED: 17560953]
American Psychiatric Asssociation. Diagnostic and Statistical Manual of Mental Disorders (DSM‐III). 3rd Edition. Washington (DC): American Psychiatric Association, 1980. [ISBN 978‐0‐89042‐0416]
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐III‐R). 3rd Edition. Washington (DC): American Psychiatric Association, 1987. [ISBN 978‐0‐89042‐0195]
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV). 4th Edition. Washington (DC): American Psychiatric Association, 1994. [ISBN 978‐0‐89042‐0610]
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐IV‐TR). 4th Edition. Washington (DC): American Psychiatric Association, 2000. [ISBN 978‐0‐89042‐0256]
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM‐5). 5th Edition. Washington (DC): American Psychiatric Association, 2013. [ISBN 978‐0‐89042‐554‐1]
Arntz A, Van den Hoorn M, Cornelis J, Verheul R, Van den Bosch W, De Bie AJ. Reliability and validity of the borderline personality disorder severity index. Journal of Personality Disorders 2003;17(1):45‐59. [PUBMED: 12659546]
Arntz A, Van Genderen H. Schema Therapy for Borderline Personality Disorder. Chichester (UK): Wiley‐Blackwell, 2009. [ISBN 978‐0‐470‐51080‐3]
Atkins D, Best D, Briss PA, Eccles M, Falck‐Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490‐9. [DOI: doi.org/10.1136/bmj.328.7454.1490; PMC428525; PUBMED: 15205295]
Ayodeji E, Green J, Roberts C, Trainor G, Rothwell J, Woodham A, et al. The influence of personality disorder on outcome in adolescent self‐harm. British Journal of Psychiatry 2015;207(4):313‐9. [DOI: 10.1192/bjp.bp.113.138941; PUBMED: 26250743]
Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401–6. [DOI: 10.1016/j.jclinepi.2010.07.015; PUBMED: 21208779]
Barrett ES, Stanford MS. Impulsiveness. In: Costello CG editor(s). Personality Characteristics of the Personality Disordered. New York (NY): Wiley, 1995:91‐118. [ISBN 978‐0‐471‐01529‐1]
Bateman A, Fonagy P. Psychotherapy for Borderline Personality Disorder: Mentalisation Based Treatment. Oxford (UK): Oxford University Press, 2004. [ISBN 978‐0‐19‐852766‐4]
Bateman A, Fonagy P. Mentalization‐Based Treatment for Borderline Personality Disorders: A Practical Guide. Oxford (UK): Oxford University Press, 2006. [ISBN 978‐0‐19‐857090‐5]
Bateman AW, Gunderson J, Mulder R. Treatment of personality disorder. Lancet 2015;385(9969):735‐43. [DOI: 10.1016/S0140‐6736(14)61394‐5]
Bateman A, Fonagy P. Mentalization‐Based Treatment for Personality Disorders: A Practical Guide. Oxford (UK): Oxford University Press, 2016. [ISBN 019968037X]
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961;4:561‐71. [PUBMED: 13688369]
Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. Journal of Consulting and Clinical Psychology 1979;47(2):343‐52. [PUBMED: 469082]
Berkey CS, Mosteller F, Lau J, Antman EM. Uncertainty of the time of first significance in random effects cumulative meta‐analysis. Controlled Clinical Trials 1996;17(5):357‐71. [PUBMED: 8932970]
Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation scale. Journal of Nervous and Mental Disease 1986;174(12):727‐35. [PUBMED: 3783140]
Biskin RS. The lifetime course of borderline personality disorder. Canadian Journal of Psychiatry 2015;60(7):303‐8. [DOI: 10.1177/070674371506000702; PMC4500179; PUBMED: 26175388]
Black DW, Blum N, Pfohl B, Hale N. Suicidal behavior in borderline personality disorder: prevalence, risk factors, prediction, and prevention. Journal of Personality Disorders 2004;18(3):226‐39. [DOI: 10.1521/pedi.18.3.226.35445; PUBMED: 15237043]
Black DW, Blum N, St John D. STEPPS: a practical, evidence‐based way to treat borderline personality disorder. Current Psychiatry 2009;8:31‐7.
Bohus M, Haaf B, Simms T, Limberger MF, Schmal C, Unckel C, et al. Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: a controlled trial. Behaviour Research and Therapy 2004;42(5):487‐99. [DOI: 10.1016/S0005‐7967(03)00174‐8; PUBMED: 15033496]
Boutron I, Moher D, Altman DG, Schulz K, Ravaud P, CONSORT Group. Extending the CONSORT statement to randomised trials of nonpharmacologic treatment: explanation and elaboration. Annals of Internal Medicine 2008;148(4):295‐309. [PUBMED: 18283207]
Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta‐analyses. Journal of Clinical Epidemiology 2008;61(8):763‐9. [DOI: 10.1016/j.jclinepi.2007.10.007; PUBMED: 18411040]
Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta‐analysis may be inconclusive ‐‐ trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta‐analyses. International Journal of Epidemiology 2009;38(1):287‐98. [DOI: 10.1093/ije/dyn188; PUBMED: 18824466]
Brunetti M, Shemilt I, Pregno S, Vale L, Oxman AD, Lord J, et al. GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence. Journal of Clinical Epidemiology 2013;66(2):140–50. [DOI: 10.1016/j.jclinepi.2012.04.012; PUBMED: 22863410]
Cailhol L, Thalamas C, Garrido C, Birmes P, Lapeyre‐Mestre M. Mental health service utilization among borderline personality disorder patients inpatient [Utilisation des services de soin par les patients hospitalisés, présentant un trouble de personnalité borderline en Midi‐Pyrénées]. L'Encéphale 2015;41(2):115‐22. [DOI: 10.1016/j.encep.2014.10.008; PUBMED: 25526809]
Chanen AM, Kaess M. Developmental pathways to borderline personality disorder. Current Psychiatry Reports 2012;14(1):45‐53. [DOI: 10.1007/s11920‐011‐0242‐y; PUBMED: 22009682]
Chanen AM, McCutcheon L, Kerr IB. HYPE: a cognitive analytic therapy‐based prevention and early intervention programme for borderline personality disorder. In: Sharp C, Tackett JL editor(s). Handbook of Borderline Personality Disorder in Children and Adolescents. New York (NY): Springer, 2014:361‐83. [ISBN 978‐1‐4939‐0590‐4]
Clarkin JF, Yeomans FE, Kernberg OF. Psychotherapy for Borderline Personality. New York (NY): John Wiley & Sons, Inc., 1999.
Clarkin JF. An integrated approach to psychotherapy techniques for patients with personality disorder. Journal of Personality Disorders 2012;26(1):43‐62. [DOI: 10.1521/pedi.2012.26.1.43; PUBMED: 22369166]
Coccaro EF, Harvey PD, Kupsaw‐Lawrence E, Herbert JL, Bernstein DP. Development of neuropharmacologically‐based behavioral assessments of impulsive aggressive behavior. Journal of Neuropsychiatry and Clinical Neurosciences 1991;3(2):S44‐S51. [PUBMED: 1821222]
Coid J, Yang M, Tyrer P, Roberts A, Ullrich S. Prevalence and correlates of personality disorder in Great Britain. British Journal of Psychiatry 2006;188:423‐31. [DOI: 10.1192/bjp.188.5.423; PUBMED: 16648528]
Cristea IA, Gentili C, Cotet CD, Palomba D, Barbui C, Cuijpers P. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta‐analysis. JAMA Psychiatry 2017;74(4):319‐28. [DOI: doi:10.1001/jamapsychiatry.2016.4287; PUBMED: 28249086]
Copenhagen Trial Unit. TSA ‐ Trial Sequential Analysis. www.ctu.dk/tsa (accessed 12 December 2016).
Curtin F, Elbourne D, Altman DG. Meta‐analysis combining parallel and cross‐over clinical trials. III: the issue of carry‐over. Statistics in Medicine 2002;21(15):2161‐73. [DOI: 10.1002/sim.1207; PUBMED: 12210631]
De Fruyt F, De Clercq B. Antecedents of personality disorder in childhood and adolescence: towards an integrative developmental model. Annual Review of Clinical Psychology 2014;10:449‐76. [DOI: 10.1146/annurev‐clinpsy‐032813‐15364; PUBMED: 24471374]
De Groot ER, Verheul R, Trijsburg RW. An integrative perspective on psychotherapeutic treatments for borderline personality disorders. Journal of Personality Disorders 2008;22(4):332‐52. [DOI: 10.1521/pedi.2008.22.4.332; PUBMED: 18684048]
Deeks JJ, Higgins JPT, Altman DG, editor(s). Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Churchill R, Chandler J, Cumpston ME, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook.
Derogatis LR, Lazarus L. SCL‐90‐R, Brief Symptom Inventory, and matching clinical rating scales. In: Maruish ME editor(s). The Use of Psychological Testing for Treatment Planning and Outcomes Assessment. Hillsdale (NJ): Lawrence Erlbaum Associates, Inc., 1994:217‐48.
Donner A, Klar N. Issues in the meta‐analysis of cluster randomized trials. Statistics in Medicine 2002;21(19):2971‐80. [DOI: 10.1002/sim.1301; PUBMED: 12325113]
Doyle M, While D, Mok PL, Windfuhr K, Ashcroft, DM, Kontopantelis E, et al. Suicide risk in primary care patients diagnosed with a personality disorder: a nested case control study. BMC Family Practice 2016;17:106. [DOI: 10.1186/s12875‐016‐0479‐y; PMC4974738; PUBMED: 27495284]
Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 1976;33(6):766‐71. [PUBMED: 938196]
Fonagy P, Luyten P. A developmental, mentalization‐based approach to the understanding and treatment of borderline personality disorder. Development and Psychopathology 2009;21(4):1355‐81. [DOI: 10.1017/S0954579409990198; PUBMED: 19825272]
Fonagy P, Allison E. The role of mentalizing and epistemic trust in the therapeutic relationship. Psychotherapy 2014;51(3):372‐80. [DOI: 10.1037/a0036505; PUBMED: 24773092]
Goodman M, Patil U, Steffel L, Avedon J, Sasso S, Triebwasser J, et al. Treatment utilization by gender in patients with borderline personality disorder. Journal of Psychiatric Practice 2010;16(3):155‐63. [DOI: 10.1097/01.pra.0000375711.47337.27; PUBMED: 20485103]
Goodman M, Roiff T, Oakes AH, Paris J. Suicidal risk and management in borderline personality disorder. Current Psychiatry Reports 2012;14(1):79‐85. [DOI: doi.org/10.1007/s11920‐011‐0249‐4; PUBMED: 22113831]
Gratz KL. Measurement of deliberate self‐harm: preliminary data on the Deliberate Self‐Harm Inventory. Journal of Psychopathology and Behavioral Assessment 2001;23(4):253‐63. [DOI: 10.1023/A:1012779403943.pdf]
Gunderson JG. Borderline personality disorder: ontogeny of a diagnosis. American Journal of Psychiatry 2009;166(5):530‐9. [DOI: 10.1176/appi.ajp.2009.08121825; NIHMS313194; PMC3145201]
Gunderson JG. Borderline personality disorder. New England Journal of Medicine 2011;364(21):2037‐42. [DOI: doi.org/10.1056/NEJMcp1007358]
Gunderson JG, Stout RL, McGlashan, TH, Shea MT, Morey LC, Grilo CM, et al. Ten‐year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Archives of General Psychiatry 2011;68(8):827‐37. [DOI: doi.org/10.1001/archgenpsychiatry.2011.37; PMC3158489; PUBMED: 21464343]
Guttierez PM, Osman A, Barrios FX, Kopper BA. Development and initial validation of the Self‐Harm Behavior Questionnaire. Journal of Personality Assessment 2001;77(3):475‐90. [DOI: 10.1207/S15327752JPA7703_08; PUBMED: 11781034]
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction ‐ GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383–94. [DOI: 10.1016/j.jclinepi.2010.04.026; PUBMED: 21195583]
Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. Journal of Clinical Epidemiology 2011;64(4):395–400. [DOI: 10.1016/j.jclinepi.2010.09.012; PUBMED: 21194891]
Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso‐Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence ‐‐ study limitations (risk of bias). Journal of Clinical Epidemiology 2011;64(4):407–15. [DOI: 10.1016/j.jclinepi.2010.07.017; PUBMED: 21247734]
Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, et al. GRADE guidelines: 5. Rating the quality of evidence ‐‐ publication bias. Journal of Clinical Epidemiology 2011;64(12):1277–82. [DOI: 10.1016/j.jclinepi.2011.01.011; PUBMED: 21802904]
Guyatt GH, Oxman AD, Kunz R, Brozek J, Alonso‐Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence ‐‐ imprecision. Journal of Clinical Epidemiology 2011;64(12):1283–93. [DOI: 10.1016/j.jclinepi.2011.01.012; PUBMED: 21839614]
Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence ‐‐ inconsistency. Journal of Clinical Epidemiology 2011;64(12):1294–302. [DOI: 10.1016/j.jclinepi.2011.03.017; PUBMED: 21803546]
Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence ‐‐ indirectness. Journal of Clinical Epidemiology 2011;64(12):1303–10. [DOI: 10.1016/j.jclinepi.2011.04.014; PUBMED: 21802903]
Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso‐Coello P, et al. GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology 2011;64(12):1311–6. [DOI: 10.1016/j.jclinepi.2011.06.004; PUBMED: 21802902]
Guyatt G, Oxman AD, Sultan S, Brozek J, Glasziou P, Alonso‐Coello P, et al. GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. Journal of Clinical Epidemiology 2013;66(2):151–7. [DOI: 10.1016/j.jclinepi.2012.01.006; PUBMED: 22542023]
Guyatt GH, Oxman AD, Santesso N, Helfand M, Vist G, Kunz R, et al. GRADE guidelines: 12. Preparing summary of findings tables ‐ binary outcomes. Journal of Clinical Epidemiology 2013;66(2):158–72. [DOI: 10.1016/j.jclinepi.2012.01.012; PUBMED: 22609141]
Guyatt GH, Thorlund K, Oxman AD, Walter SD, Patrick D, Furukawa TA, et al. GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles ‐ continuous outcomes. Journal of Clinical Epidemiology 2013;66(2):173–83. [DOI: 10.1016/j.jclinepi.2012.08.001; PUBMED: 23116689]
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327(7414):557‐60. [DOI: https://doi.org/10.1136/bmj.327.7414.557; PMC192859; PUBMED: 12958120]
Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. [Available from: www.training.cochrane.org/handbook]
Higgins JPT, Deeks JJ, Altmand DG, editor(s). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Higgins JPT, Altman DG, Sterne JAC, editor(s). Chapter 8: Assessing risk of bias. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook.
Horowitz LM, Rosenberg SE, Baer BA, Ureño G, Villaseñor VS. Inventory of interpersonal problems: psychometric properties and clinical applications. Journal of Consulting and Clinical Psychology 1988;56(6):885‐92. [PUBMED: 3204198]
Horvath AO, Del Re AC, Flückiger C, Symonds D. Alliance in individual psychotherapy. Psychotherapy 2011;48(1):9‐16. [DOI: 10.1037/a0022186; PUBMED: 21401269]
Huprich SK. Personality Disorders: Toward Theoretical and Empirical Integration in Diagnosis and Assessment. Washington (DC): American Psychological Association, 2015. [ISBN 978‐1‐4228‐1846‐2]
Hutsebaut J, Bales DL, Busschbach JJ, Verheul R. The implementation of mentalization‐based treatment for adolescents: a case study from an organizational, team and therapist perspective. International Journal of Mental Health Systems 2012;6(1):10. [DOI: 10.1186/1752‐4458‐6‐10; PMC3447734; PUBMED: 22818166]
Hörz S, Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Ten‐year use of mental health services by patients with borderline personality disorder and with other axis II disorders. Psychiatric Services 2010;61(6):612‐6. [DOI: 10.1176/ps.2010.61.6.612; PMC3889171; PUBMED: 20513685]
International Council for Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice E6(R1). www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6/E6_R1_Guideline.pdf (accessed 6 May 2011).
Jakobsen JC, Gluud C, Winkel P, Lange T, Wetterslev J. The thresholds for statistical and clinical significance – a five‐step procedure for evaluation of intervention effects in randomised clinical trials. BMC Medical Research Methodology 2014;14:34. [DOI: 10.1186/1471‐2288‐14‐34; PMC4015863; PUBMED: 24588900]
Kazdin AE. Psychotherapy for children and adolescents. In: Lambert MJ editor(s). Bergin and Garfield's Handbook of Psychotherapy and Behavior Change. 5th Edition. New York (NY): John Wiley & Sons, Inc., 2004:543‐89. [ISBN 0‐471‐37755‐4]
Kernberg OF. Borderline Conditions and Pathological Narcissism. New York (NY): Aronson, 1975.
Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses. Annals of Internal Medicine 2001;135(11):982‐9. [PUBMED: 11730399]
Kliem S, Kröger C, Kosfelder J. Dialectical behavior therapy for borderline personality disorder: a meta‐analysis using mixed‐effects modeling. Journal of Consulting and Clinical Psychology 2010;78(6):936‐51. [DOI: 10.1037/a0021015; PUBMED: 21114345]
Kongerslev MT, Chanen AM, Simonsen E. Personality disorder in childhood and adolescence comes of age: a review of the current evidence and prospects for future research. Scandinavian Journal of Child and Adolescent Psychiatry and Psychology 2015;3(1):31‐48. [DOI: 10.21307/sjcapp‐2015‐004]
Lau J, Schmid CH, Chalmers TC. Cumulative meta‐analysis of clinical trials builds evidence for exemplary medical care. Journal of Clinical Epidemiology 1995;48(1):45‐57. [PUBMED: 7853047]
Lenzenweger MF, Lane MC, Loranger AW, Kessler RC. DSM‐IV personality disorders in the National Comorbidity Survey Replication. Biological Psychiatry 2007;62(6):553‐64. [DOI: 10.1016/j.biopsych.2006.09.019; PMC2044500; PUBMED: 17217923]
Levine J, Schooler NR. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacology Bulletin 1986;22(2):343‐81. [PUBMED: 3774930]
Lieb K, Zanarini MC, Schmahl C, Linehan MM, Bohus M. Borderline personality disorder. Lancet 2004;364(9432):453‐61. [DOI: dx.doi.org/10.1016/S0140‐6736(04)16770‐6; PUBMED: 15288745]
Lilienfeld SO. Psychological treatments that cause harm. Perspectives on Psychology Science 2007;2(1):53‐70. [doi: 10.1111/j.1745‐6916.2007.00029.x; PUBMED: 26151919]
Linehan MM. Cognitive‐Behavioral Treatment of Borderline Personality Disorder. New York (NY): The Guilford Press, 1993. [ISBN 0‐89862‐183‐6]
Linehan MM. Behavioral treatments of suicidal behaviors. Definitional obfuscation and treatment outcomes. Annals of the New York Academy of Sciences 1997;836:302‐28. [DOI: 10.1111/j.1749‐6632.1997.tb52367.x; PUBMED: 9616806]
Linehan MM. DBT® Skills Training Manual. New York (NY): The Guilford Press, 2015. [ISBN 978‐1‐4625‐1699‐5]
Links PS, Kolla N. Assessing and managing suicide risk. In: Oldham JM, Skodol AE, Bender DS editor(s). Essentials of Personality Disorders. Arlington (VA): American Psychiatric Publishing, Inc., 2009:343‐60. [ISBN 978‐1‐58562‐358‐7]
Links PS, Ross J, Gunderson JG. Promoting good psychiatric management for patients with borderline personality disorder. Journal of Clinical Psychology 2015;71(8):753‐63. [DOI: 10.1002/jclp.22203; PUBMED: 26197971]
Livesley WJ. Practical Management of Personality Disorder. New York (NY): The Guilford Press, 2003. [ISBN 1‐57230‐889‐3]
Livesley WJ. Changing ideas about the treatment of borderline personality disorder. Journal of Contemporary Psychotherapy 2004;34(3):185‐92. [DOI: 10.1023/B:JOCP.0000036697.03467.27]
Livesley WJ. Moving beyond specialized therapies for borderline personality disorder: the importance of integrated domain‐focused treatment. Psychodynamic Psychiatry 2012;40(1):47‐74. [DOI: 10.1521/pdps.2012.40.1.4; PUBMED: 23006029]
Livesley WJ, Dimaggio G, Clarkin JF, editor(s). Integrated Treatment for Personality Disorder: A Modular Approach. New York (NY): The Guilford Press, 2016. [ISBN 978‐1‐4625‐2288‐0]
Loke YK, Price D, Herxheimer A. Chapter 14: Adverse effects. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2]
Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analysis?. Lancet 1998;352(9128):609‐13. [DOI: 10.1016/S0140‐6736(98)01085‐X; PUBMED: 9746022]
Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta‐analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta‐analyses. Lancet 1999;354(9193):1896‐900. [PUBMED: 10584742]
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979;134:382‐9. [PUBMED: 444788]
Munk‐Jørgensen P, Najarraq Lund M, Bertelsen A. Use of ICD‐10 diagnoses in Danish psychiatric hospital‐based services in 2001‐2007. World Psychiatry 2010;9(3):183‐4. [ PMC2948730; PUBMED: 20975866]
Mustafa RA, Santesso N, Brozek J, Akl EA, Walter SD, Norman G, et al. The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses. Journal of Clinical Epidemiology 2013;66(7):736‐42. [DOI: 10.1016/j.jclinepi.2013.02.004; PUBMED: 23623694]
Ng FY, Bourke ME, Grenyer BFS. Recovery from borderline personality disorder: a systematic review of the perspectives of consumers, clinicians, family and carers. PLoS ONE 2016;11(8):e0160515. [DOI: 10.1371/journal.pone.0160515; PMC4978398; PUBMED: 27504634]
Niesten IJ, Karan E, Frankenburg FR, Fitzmaurice GM, Zanarini MC. Description and prediction of the income status of borderline patients over 10 years of prospective follow‐up. Personality and Mental Health 2016;10(4):285‐92. [DOI: 10.1002/pmh.1331; PUBMED: 26864557]
US National Library of Medicine. Medical Subject Headings (MeSH Browser). meshb.nlm.nih.gov/search (accessed 31 March 2009).
Norcross JC, editor(s). Psychotherapy Relationships That Work: Evidence‐Based Responsiveness. 2nd Edition. New York (NY): Oxford University Press, Inc., 2011. [ISBN 978‐0‐19‐973720‐8]
Osman A, Bagge CL, Gutierrez PM, Konick LC, Kopper BA, Barrios FX. The Suicidal Behaviors Questionnaire‐Revised (SBQ‐R): validation with clinical and nonclinical samples. Assessment 2001;8(4):443‐54. [DOI: dx.doi.org/10.1177/107319110100800409; PUBMED: 11785588]
Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychological Reports 1962;10(3):799‐812. [DOI: 10.2466/pr0.1962.10.3.799]
Paris J, Gunderson J, Weinberg I. The interface between borderline personality disorder and bipolar spectrum disorders. Comprehensive Psychiatry 2007;48(2):145‐54. [DOI: 10.1016/j.comppsych.2006.10.001; PUBMED: 17292705]
Parry GD, Crawford MJ, Duggan C. Iatrogenic harm from psychological therapies ‐‐ time to move on. British Journal of Psychiatry 2016;208(3):210‐12. [DOI: 10.1192/bjp.bp.115.163618; PUBMED: 26932481]
Perez V, Barrachina J, Soler J, Pascual JC, Campins MJ, Puigdemont D, et al. The clinical global impression scale for borderline personality disorder patients (CGI‐BPD): a scale sensible to detect changes [Impresión clinica global para pacientes con trastorno límite de la personalidad (ICG‐TLP): una escala sensible al cambio]. Actas Espanolas de Psiquiatria 2007;35(4):229‐35. [PUBMED: 17592784]
Reiss N, Lieb K, Arntz A, Shaw IA, Farrell J. Responding to the treatment challenge of patients with severe BPD: results of three pilot studies of inpatient schema therapy. Behavioural and Cognitive Psychotherapy 2014;42(3):355‐67. [DOI: 10.1017/S1352465813000027; PUBMED: 23458343]
Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rossouw TI, Fonagy P. Mentalization‐based treatment for self‐harm in adolescents: a randomized controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry 2012;51(12):1304‐13. [DOI: 10.1016/j.jaac.2012.09.018; PUBMED: 23200287]
Ryle A. Cognitive Analytic Therapy and Borderline Personality Disorder: The Model and the Method. Chichester (UK): John Wiley & Sons, Inc., 1997. [ISBN‐13: 978‐0471976189]
Savović J, Jones H, Altman D, Harris R, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta‐epidemiological studies. Health Technology Assessment 2012;16(35):1‐82. [DOI: 10.3310/hta16350; PUBMED: 22989478]
Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine 2012;157(6):429‐38. [DOI: 10.7326/0003‐4819‐157‐6‐201209180‐00537; PUBMED: 22945832]
Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408‐12. [PUBMED: 7823387]
Skodol AE, Gunderson JG, McGlashan TH, Dyck IR, Stout RL, Bender DS, et al. Functional impairment in patients with schizotypal, borderline, avoidant, or obsessive‐compulsive personality disorder. American Journal of Psychiatry 2002;159(2):276‐83. [DOI: 10.1176/appi.ajp.159.2.276; PUBMED: 11823271]
Soeteman DI, Hakkaart‐van Roijen L, Verheul R, Busschbach JJV. The economic burden of personality disorders in mental health care. Journal of Clinical Psychiatry 2008;69(2):259–65. [PUBMED: 18363454]
Soeteman DI, Verheul R, Busschbach JJV. The burden of disease in personality disorders: diagnosis‐specific quality of life. Journal of Personality Disorders 2008;22(3):259‐68. [DOI: doi.org/10.1521/pedi.2008.22.3.259; PUBMED: 18540798]
Soloff PH, Lynch KG, Kelly TM. Childhood abuse as a risk factor for suicidal behavior in borderline personality disorder. Journal of Personality Disorders 2002;16(3):201‐14. [PUBMED: 12136678]
Spielberger CD. Manual for the State‐Trait Anger Expression Inventory. Odessa (FL): Psychological Assessment Resources, 1988.
Stepp SD. Development of borderline personality disorder in adolescence and young adulthood: introduction to the special section. Journal of Abnormal Child Psychology 2012;40(1):1‐5. [DOI: 10.1007/s10802‐011‐9594‐3; PMC3865353; PUBMED: 22116635]
Stern A. Psychoanalytic investigation of and therapy in the borderline group of neuroses. Psychoanalytic Quarterly 1938;7:467‐89.
Sterne JAC, Egger M, Moher D, Boutron I, editor(s). Chapter 10: Addressing reporting biases. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). Cochrane, 2017. Available from www.training.cochrane.org/handbook.
Stiglmayr CE, Grathwol T, Linehan MM, Ihorst G, Fahrenberg J, Bohus M. Aversive tension in patients with borderline personality disorder: a computer‐based controlled field study. Acta Psychiatrica Scandinavica 2005;111(5):372‐9. [DOI: 10.1111/j.1600‐0447.2004.00466.x; PUBMED: 15819731]
Stone MH. Long‐term outcome in personality disorders. British Journal of Psychiatry 1993;162(3):299‐313. [DOI: 10.1192/bjp.162.3.299; PUBMED: 8453424]
Storebø OJ, Simonsen E. Is ADHD an early stage in the development of borderline personality disorder?. Nordic Journal of Psychiatry 2014;68(5):289‐95. [DOI: 10.3109/08039488.2013.841992; PUBMED: 24117059]
Ten Have M, Verheul R, Kaasenbrood A, van Dorsselaer, S, Tuithof M, Kleinjan M, et al. Prevalence rates of borderline personality disorder symptoms: a study based on the Netherlands Mental Health Survey and Incidence Study‐2. BMC Psychiatry 2016;16:249. [DOI: doi.org/10.1186/s12888‐016‐0939‐x; PMC4949762; PUBMED: 27435813]
Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta‐analysis?. International Journal of Epidemiology 2009;38(1):276‐86. [DOI: 10.1093/ije/dyn179; PUBMED: 18824467]
Tomko RL, Trull TJ, Wood PK, Sher KJ. Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning. Journal of Personality Disorders 2014;28(5):734‐50. [DOI: doi.org/10.1521/pedi_2012_26_093; PMC3864176; PUBMED: 25248122]
Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Archives of general psychiatry 2001;58(6):590–6. [PUBMED: 11386989]
Torgersen S. Epidemiology. In: Widiger TA editor(s). The Oxford Handbook of Personality Disorders. New York (NY): Oxford University Press, 2012:186‐205. [DOI: 10.1093/oxfordhb/9780199735013.013.0009; ISBN 978‐0‐19‐973501‐3]
Tyrer P, Nur U, Crawford M, Karlsen S, McLean C, Rao B, et al. The Social Functioning Questionnaire: a rapid and robust measure of perceived functioning. International Journal of Social Psychiatry 2005;51(3):265‐75. [PUBMED: 16252794]
Tyrer P, Reed GM, Crawford MJ. Classification, assessment, prevalence, and effect of personality disorders. Lancet 2015;385(9969):717‐26. [DOI: 10.1016/S0140‐6736(14)61995‐4]
van Asselt AD, Dirksen CD, Arntz A, Severens JL. The cost of borderline personality disorder: societal cost of illness in BPD‐patients. European Psychiatry 2007;22(6):354‐61. [DOI: doi:10.1016/j.eurpsy.2007.04.001; PUBMED: 17544636]
Weinberg I, Ronningstam E, Goldblatt MJ, Schechter M, Maltsberger JT. Common factors in empirically supported treatments of borderline personality disorder. Current Psychiatry Reports 2011;13(1):60‐8. [DOI: 10.1007/s11920‐010‐0167‐x; PUBMED: 21057901]
Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta‐analysis. Journal of Clinical Epidemiology 2008;61(1):64‐75. [DOI: 10.1016/j.jclinepi.2007.03.013; PUBMED: 18083463]
Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random‐effects model meta‐analyses. BMC Medical Research Methodology 2009;9:86. [DOI: 10.1186/1471‐2288‐9‐86; PMC2809074; PUBMED: 20042080]
World Health Organization. The ICD‐10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva (CH): World Health Organization, 1993.
Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ 2008;336(7644):601‐5. [DOI: 10.1136/bmj.39465.451748.AD; PMC2267990; PUBMED: 18316340]
Yen S, Shea MT, Sanislow CA, Grilo CM, Skodol AE, Gunderson JG, et al. Borderline personality disorder criteria associated with prospectively observed suicidal behavior. American Journal of Psychiatry 2004;161(7):1296‐8. [DOI: doi.org/10.1176/appi.ajp.161.7.1296; PUBMED: 15229066]
Yeomans FE, Clarkin JF, Kernberg OF. Transference‐Focused Psychotherapy for Borderline Personality Disorder: A Clinical Guide. Arlington (VA): American Psychiatric Publishing, 2015. [ISBN 978‐1‐58562‐437‐9]
Young JE, Klosko JS, Weishaar ME. Schema Therapy: A Practitioner's Guide. New York (NY): The Guilford Press, 2003.
Zanarini MC, Frankenburg FR, DeLuca CJ, Hennen J, Khera, GS, Gunderson JG. The pain of being borderline: dysphoric states specific to borderline personality disorder. Harvard Review of Psychiatry 1998;6(4):201‐7. [DOI: 10.3109/10673229809000330; PUBMED: 10370445]
Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. Zanarini Rating Scale for Borderline Personality Disorder (Zan‐BPD): a continuous measure of DSM‐IV borderline psychopathology. Journal of Personality Disorders 2003;17(3):233‐42. [DOI: 10.1521/pedi.17.3.233.22147; PUBMED: 12839102]
Zanarini MC, Frankenburg FR, Hennen J, Silk KR. Mental health service utilization by borderline personality disorder patients and Axis II comparison subjects followed prospectively for 6 years. Journal of Clinical Psychiatry 2004;65(1):28‐36. [PUBMED: 14744165]
Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. The McLean Study of Adult Development (MSAD): overview and implications of the first six years of prospective follow‐up. Journal of Personality Disorders 2005;19(5):505‐23. [DOI: 10.1521/pedi.2005.19.5.505; PUBMED: 16274279]
Zanarini MC, Frankenburg FR, Reich DB, Silk KR, Hudson JI, McSweeney LB. The subsyndromal phenomenology of borderline personality disorder: a 10‐year follow‐up study. American Journal of Psychiatry 2007;164(6):929‐35. [DOI: 10.1176/ajp.2007.164.6.929; PUBMED: 17541053]
Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. The 10‐year course of psychosocial functioning among patients with borderline personality disorder and axis II comparison subjects. Acta Psychiatrica Scandinavica 2010;122(2):103‐9. [DOI: doi:10.1111/j.1600‐0447.2010.01543.x; PMC3876887; PUBMED: 20199493]
Zanarini MC, Frankenburg FR, Reich B, Fitzmaurice G. Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: a 16‐year prospective follow‐up study. American Journal of Psychiatry 2012;169(5):476‐83. [DOI: 10.1176/appi.ajp.2011.11101550; PMC3509999; PUBMED: 22737693]
Zanarini MC, Frankenburg FR, Reich DB, Conkey LC, Fitzmaurice GM. Rates of psychiatric treatment reported by patients with borderline personality disorder and other personality disorders over 16 years of prospective follow‐up. Psychiatric Services 2015;66(1):15‐20. [DOI: 10.1176/appi.ps.201400055; NIHMS597508; PMC4283568]
Zanarini MC, Frankenburg FR, Reich DB, Harned AL, Fitzmaurice GM. Rates of psychotropic medication use reported by borderline patients and axis II comparison subjects over 16 years of prospective follow‐up. Journal of Clinical Psychopharmacology 2015;35(1):63‐7. [DOI: 10.1097/JCP.0000000000000232; NIHMS620539; PMC4276426]
References to other published versions of this review
Ir a:
Binks C, Fenton M, McCarthy L, Lee T, Adams CE, Duggan C. Psychological therapies for people with borderline personality disorder. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858.CD005652]
Stoffers‐Winterling JM, Völlm BA, Rücker G, Timmer A, Huband N, Lieb K. Psychological therapies for people with borderline personality disorder. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD005652.pub2]
